Product Information
BUDESONIDE ER 9 MG TABLET is a generic product labeled by Oceanside Pharmaceuticals, priced at $13.6545 per EA under NDC 68682030930. Its NADAC has been published 364 times since Oct 17, 2018.
FDA first approved this application on Jan 14, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
9 mg/1
Manufacturer
Oceanside PharmaceuticalsNDC
68682030930
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
BUDESONIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA203634FDA Approved
1/14/2013
TE Code
AB
On Market Since
7/10/2018
Pharmacological Classes
Price Statistics
The NADAC for BUDESONIDE ER 9 MG TABLET has been published 364 times since Oct 17, 2018, and over the history we have for it it has declined 67.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.6545 per EA |
|---|---|
| All-time high | $44.5486 (Dec 12, 2018) |
| All-time low | $13.6545 (Sep 17, 2025) |
| Median price | $31.3711 |
| Average price | $30.2636 |
| Largest weekly change | -35.3% (Apr 17, 2024) |
| Weeks tracked | 364 |
| Tracking since | Oct 17, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-52.1%
5Y
-54.1%
All
-67.6%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oceanside Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
budesonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUDESONIDE ER 9 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE ER 9 MG TABLET, manufactured by Oceanside Pharmaceuticals, is $13.6545 per EA (NDC 68682030930), effective Oct 1, 2025.
How has the price of BUDESONIDE ER 9 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUDESONIDE ER 9 MG TABLET has declined 67.6%. It has been tracked across 364 weekly CMS publications since Oct 17, 2018.
What are the highest and lowest recorded NADAC prices for BUDESONIDE ER 9 MG TABLET?
Since Oct 17, 2018, the NADAC for BUDESONIDE ER 9 MG TABLET has ranged from a low of $13.6545 (Sep 17, 2025) to a high of $44.5486 (Dec 12, 2018), with a median of $31.3711 per EA.
Are there cheaper alternatives to BUDESONIDE ER 9 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BUDESONIDE ER 9 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BUDESONIDE ER 9 MG TABLET?
BUDESONIDE ER 9 MG TABLET (NDC 68682030930) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.